China Cancer Drugs Market to reach US$ 30 Billion by 2024

1
China Cancer Drugs Market
Category Drugs Pharmaceuticals Market Report
2
China Cancer Drugs Market Analyst View China
Cancer Drugs Market is projected to reach US 30
Billion by the year 2024. Get Free Customization
in this Report Research Report Title China
Cancer Drugs Market, by Drugs Cytotoxic Drugs
(Antimetabolities, Plant Alkaloids, Alkylating
Agents), Targeted Drugs, Monoclonal Antibiotics,
Hormonal Drugs, Traditional Chinese Medicine
(TCM), Others, Cancer (Lung, Stomach, Breast,
Esophageal, Liver Others), Therapy
(Chemotherapy, Targeted Therapy, Hormonal Therapy
Others), Companies (Merck, Celgene, Eli Lilly,
Roche Sino BioPharma) Access Full
Research  https//www.renub.com/china-cancer-drug
s-market-p.php

3
China Cancer Drugs Market is projected to reach
US 30 Billion by the year 2024.
Anti-Cancer drugs are the drugs which are used to
reduce or prevent the cell proliferation of
cancerous tissues. China Cancer Drugs Market is
projected to reach US 30 Billion by the
year 2024 owing to the increasing prevalence of
various types of cancer, changing lifestyle
dietary habits, growing aging population, rising
demand of targeted drug therapy and the patent
expiration of key cancer drugs. Cancer is one of
the leading causes of death worldwide and is a
major public health burden in both developed and
developing countries.   The rate of cancer
incidences in China is exploding very rapidly
nearly 4 million people diagnosed and almost 3
million died from it. For instance due to
increasing air pollution over the last couple of
years, lung cancer has increased 50 in Beijing
only. Anticancer drugs act like an inhibitor that
prevents cancer cells to grow.

4
China Cancer Drugs Market is projected to reach
US 30 Billion by the year 2024.
In addition factors like growing awareness
regarding cancer diagnosis treatment,
advancement in cancer drugs and therapies, rise
in cancer awareness programs like breast cancer
screening, investment in healthcare
infrastructure are expected to drive China
anti-cancer drugs market positively over the
forecast period. However, major side-effects of
cancer drugs and its high cost are certainly
restraining the China anti-cancer drugs market to
reach its full potential. Request a free sample
copy of the report https//www.renub.com/contactu
s.php Renub Research report titled China
Cancer Drugs Market, by Drugs Cytotoxic Drugs
(Antimetabolities, Plant Alkaloids, Alkylating
Agents), Targeted Drugs, Monoclonal Antibiotics,
Hormonal Drugs, Traditional Chinese Medicine
(TCM), Others, Cancer (Lung, Stomach, Breast,
Esophageal, Liver Others), Therapy
(Chemotherapy, Targeted Therapy, Hormonal Therapy
Others), Companies (Merck, Celgene, Eli Lilly,
Roche Sino BioPharma) provides a complete
analysis of China Anti-Cancer Drugs Market.

5
China Cancer Drugs Market is projected to reach
US 30 Billion by the year 2024.

6
China Cancer Drugs Market is projected to reach
US 30 Billion by the year 2024.
By Drugs Cytotoxic Drugs leads the Cancer Drugs
Market in China Based on the drugs type, China
cancer drugs market is segmented into cytotoxic
drugs, targeted drugs, Monoclonal Antibiotics,
hormonal drugs, TCM and Others. The cytotoxic
drugs segment is further classified into
Antimetabolites, Plant Alkaloids and Alkylating
Agents.  By Cancer Lungs Cancer accounts for
the largest share of China Cancer Drugs Market On
the basis of cancer type, China cancer drugs
market is segmented into Lung, Stomach, Breast,
Esophageal, Liver Others. Lung, Breast and
Stomach Cancer dominates the China anti-cancer
drugs market and is expected to do so in the near
future.    By Therapy Targeted Therapy is
expected to grow significantly during the
forecast period By therapy type, the China
anti-cancer drugs market is segmented into
chemotherapy, targeted therapy, hormonal therapy
and others. Chemotherapy and targeted therapy
together held the major share of China cancer
drugs market. 

7
China Cancer Drugs Market is projected to reach
US 30 Billion by the year 2024.
Company Analysis Some of the prominent companies
competing in the China Anti-Cancer Drugs Market,
and profiled in the report include Merck,
Celegene, Eli Lilly, Roche and Sino
BioPharma.  This market research report provides
a complete analysis of the China Cancer Drugs
Market, Growth Drivers, Challenges, and their
projections for the upcoming years. Client can
Purchase this Report in Sections from below
link Access full Research https//www.renub.co
m/china-cancer-drugs-market-p.php   By Drugs   
 Cytotoxic Drugs  o    Antimetabolities o  
 Plant Alkaloids o    Alkylating Agents    
 Targeted Drugs     Monoclonal Antibiotics   
 Hormonal Drugs    Traditional Chinese Medicine
(TCM)     Others

8
China Cancer Drugs Market is projected to reach
US 30 Billion by the year 2024.
By Cancer     Lung Cancer     Stomach
Cancer    Breast Cancer     Esophageal
Cancer    Liver Cancer     Others By
Therapy     Chemotherapy     Targeted
Therapy    Hormonal Therapy   
 Others Companies Covered in the Report   
 Merck     Celegene    Eli Lilly   
 Roche    Sino BioPharma

9
Table of Contents for China Cancer Drugs Market
Key Topics Covered 1. Executive Summary 2.  
 China Cancer Drugs Market 3.    Market Share
China Anti-Cancer Drugs 3.1    By Drugs 3.2  
 By Cancer3.3    By Therapy 4.    Drugs China
Cancer Market 4.1    Cytotoxic Drugs 4.2  
 Targeted Drugs4.3    Monoclonal
Antibiotics 4.4    Hormonal Drugs4.5  
 Traditional Chinese Medicine 4.6    Others 5.  
 Cancer Type Market 5.1    Lung Cancer 5.2  
 Stomach Cancer5.3    Breast Cancer 5.4  
 Esophageal Cancer5.5    Liver Cancer 5.6  
 Others

10
Table of Contents for China Cancer Drugs Market
6.    Therapy China Cancer Market 6.1  
 Chemotherapy 6.2    Targeted Therapy6.3  
 Hormonal Therapy 6.4    Others 7.    Company
Analysis 7.1    Merck 7.2    Celgene 7.3  
 Eli Lilly 7.4    Roche 7.5    Sino
BioPharma 8.    Growth Drivers 8.1    Growing
Awareness towards Cancer Diagnosis and
Treatment8.2    Increasing Use of Targeted
Therapy8.3    Increasing Research and
Development Activities8.4    Cutting Import
Duties on Cancer Drugs 9.    Challenges 9.1  
 High Cost of Cancer Drugs9.2    Major Side
Effects of Cancer Treatment

11
Get Free Customization in this Report
Drugs Pharmaceuticals Market Reports
https//www.renub.com/drugs-and-pharmaceuticals-
13-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel [phone] Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel [phone] Email info_at_renub.com www.renub.com